Cervical Cancer is Preventable – Even Amidst COVID-19

Half of women with cervical cancer will die — all from a disease that is completely preventable with the right resources and tools.

It doesn’t have to be this way.

As we pivot our health programming in response to COVID-19, we must ensure that cervical cancer screening and prevention remain an essential part of ongoing sexual and reproductive health (SRH) services where possible.

When adolescent girls can access HPV vaccines and women can attain cervical screening and early treatment, we’ll be closer than ever before to eliminating cervical cancer once and for all.

That can’t stop amidst COVID-19.

PSI works with government​s ​and partners to support 19 countries​’ efforts to eliminate cervical cancer. This video documents how.

On April 29, PSI’s Global Medical Health Director Dr. Eva Lathrop joined TogetHER, alongside SRH organizations and experts including the King’s Cancer Prevention Group, Celina Schocken, Chemtai Mungo, MD, MPH, CRUK Policy, Joel Fokom Domgue, Jhpiego, MD Anderson Cancer Center, PATH, and The Center for AIDS Prevention Studies (CAPS)/ Prevention Research Center (PRC) for a Twitter chat – “COVID-19 & Cervical Cancer: Implications for Service Delivery.” Partners discussed the pandemic’s impact on cervical cancer prevention and treatment services, and the measures that we can emplace to ensure no woman nor girl dies from a disease that we can prevent.

To read the full #covidcervixchat, we’ve collected all posts below:

[custom-twitter-feeds hashtag=”#covidcervixchat” num=4 showheader=false]

Sign up to
Receive Updates

Donate to
Support Our Work